Rachel Doran: Senior Regulatory Affairs Specialist
Lab / Organization: Cepheid
I investigated how viral envelope protein glycosylation variances introduced by in vitro expression systems commonly used for commercial vaccine development affect vaccine antigen immunogenicity and antigenicity during my fellowship year. Now, I work on development of in vitro diagnostic tests for infectious disease, which I am thrilled to be working in. It is an area I believe to be a critical intersection of science and public health. I find gratification in the fact that I am able to use my background in molecular biology and infectious disease, and a mindset for translational research developed during my fellowship year, to contribute the development of products that can have widespread impact on the detection and treatment of infectious disease around the world. I am excited for the rapidly growing potential of diagnostic technologies, and look forward to contributing to the development of diagnostic tests for emerging infectious diseases and beyond.